Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Mitchell
News Release
Evzio Naloxone Auto-Injectors Discontinued
Kaleo, the makers of Evzio, have recently discontinued the prod
Workers' Comp
News Release
Business Insurance: Lack of guidelines complicates COVID-19 care
Evidence-based medicine is a mainstay in the workers compensation industry, and those aiming to treat workers with COVID-19 are relying on an
Workers' Comp
Blog
Look for a Broken Spirit, Not Just a Broken Bone
As featured on the workcompwire.com blog, this piece was contributed by Tammy Bradly, Vice President, Clinical Product Develo
Mitchell
News Release
FDA Approves Veklury (Remdesivir) for Treatment of Hospitalized COVID-19 Patients
On October 22, 2020, the Food and Drug Administration (FDA)
Workers' Comp
Case Study
A Higher Calling
Catastrophic Case Management Meet Stephanie, CCM, RN Catastrophic case managers must be equipped t
Workers' Comp
Virtual Event
National Comp Virtual Conference and Ongoing Digital Series
On-Demand
The National Comp Virtual Conference and Ongoing Digital Series w